Tao Dong | Academic Influence

Tao Dong's AcademicInfluence.com Rankings

Tao Dong

Biology

#12351

World Rank

#15822

Historical Rank

Virology

#350

World Rank

#358

Historical Rank

Immunology

#864

World Rank

#887

Historical Rank

biology Degrees

Download Badge

Biology

Tao Dong's Degrees

Bachelors Biology Peking University
PhD Immunology Tsinghua University

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2025

Why Is Tao Dong Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Tao Dong is a Chinese-British immunologist who is Professor of Immunology at Oxford University. Her work focuses on the study of T-cells which respond to viral infections and viral associated cancer. She is a founding director for both the CAMS-Oxford joint International Center for Transnational Immunology and the Chinese Academy of Medical Sciences Oxford Institute .

(See a Problem?)

Tao Dong's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK (2020) (3297)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (2020) (1480)
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (2020) (1079)
HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function (2000) (1010)
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (2020) (884)
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19 (2020) (884)
Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans (2012) (853)
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera (2021) (850)
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (1995) (849)
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever (2003) (815)
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials (2021) (812)
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum (2021) (576)
Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection (2004) (463)
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. (2008) (446)
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. (1998) (437)
Antibody evasion by the P.1 strain of SARS-CoV-2 (2021) (427)
HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi1 (2000) (412)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera (2021) (373)
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (2020) (367)
Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. (2008) (334)
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison (2020) (331)
Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific (2004) (323)
Longitudinal COVID-19 profiling associates IL-1Ra and IL-10 with disease severity and RANTES with mild disease. (2020) (263)
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine (2007) (261)
Cutting Edge: Allele-Specific and Peptide-Dependent Interactions between KIR3DL1 and HLA-A and HLA-B12 (2007) (251)
Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans (2012) (247)
CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects. (2001) (239)
The antigenic anatomy of SARS-CoV-2 receptor binding domain (2021) (239)
Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses. (2001) (239)
Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals (2013) (238)
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses (2020) (228)
Evasion of Cytotoxic T Lymphocyte (CTL) Responses by Nef-dependent Induction of Fas Ligand (CD95L) Expression on Simian Immunodeficiency Virus–infected Cells (1997) (207)
Viruses transfer the antiviral second messenger cGAMP between cells (2015) (186)
T Cell Cross-Reactivity and Conformational Changes during TCR Engagement (2004) (171)
Early T-Cell Responses to Dengue Virus Epitopes in Vietnamese Adults with Secondary Dengue Virus Infections (2005) (168)
The Antigenic Anatomy of SARS-CoV-2 Receptor Binding Domain (2020) (139)
Increased frequencies of CD4+CD25high regulatory T cells in acute dengue infection (2007) (135)
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57 (2002) (133)
Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood (2016) (130)
HIV-specific Cytotoxic T Cells from Long-Term Survivors Select a Unique T Cell Receptor (2004) (129)
Interferon-Induced Transmembrane Protein 3 Genetic Variant rs12252-C Associated With Disease Severity in Coronavirus Disease 2019 (2020) (123)
Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-γ Contributes to Modulate Immune Responses* (2011) (121)
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent COVID-19 patients (2020) (120)
Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. (1999) (115)
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity (2021) (112)
Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope (2006) (110)
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection1 (2006) (107)
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers. (2001) (105)
High Pro-Inflammatory Cytokine Secretion and Loss of High Avidity Cross-Reactive Cytotoxic T-Cells during the Course of Secondary Dengue Virus Infection (2007) (101)
Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. (1997) (94)
Expansion and Diversification of Virus-Specific T Cells following Immunization of Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals with a Recombinant Modified Vaccinia Virus Ankara/HIV-1 Gag Vaccine (2006) (94)
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern (2021) (93)
Timing of CD8+ T Cell Responses in Relation to Commencement of Capillary Leakage in Children with Dengue (2010) (90)
Clinical and epidemiological features of COVID-19 family clusters in Beijing, China (2020) (88)
Acute cytomegalovirus infection in Kenyan HIV-infected infants (2009) (88)
HLA‐C as a mediator of natural killer and T‐cell activation: spectator or key player? (2011) (88)
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses (2020) (88)
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection. (2007) (87)
Generation of Murine CTL by a Hepatitis B Virus-Specific Peptide and Evaluation of the Adjuvant Effect of Heat Shock Protein Glycoprotein 96 and Its Terminal Fragments1 (2005) (86)
A Novel Scoring System for Prediction of Disease Severity in COVID-19 (2020) (85)
Distinct Recognition of Non-Clade B Human Immunodeficiency Virus Type 1 Epitopes by Cytotoxic T Lymphocytes Generated from Donors Infected in Africa (1999) (83)
Critical Role of Endoplasmic Reticulum Aminopeptidase 1 in Determining the Length and Sequence of Peptides Bound and Presented by HLA–B27 (2014) (81)
How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection? (2001) (81)
Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8+ T cell epitopes. (2007) (78)
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis. (2018) (78)
Quantitating T Cell Cross-Reactivity for Unrelated Peptide Antigens1 (2009) (76)
Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children (2015) (74)
Antigen Potency and Maximal Efficacy Reveal a Mechanism of Efficient T Cell Activation (2011) (70)
Activated innate lymphoid cell populations accumulate in human tumour tissues (2018) (70)
HIV Type 1 Resistance in Kenyan Sex Workers Is Not Associated with Altered Cellular Susceptibility to HIV Type 1 Infection or Enhanced β-Chemokine Production (1998) (69)
High levels of virus-specific CD4+ T cells predict severe pandemic influenza A virus infection. (2012) (68)
Reduction of Natural Killer but Not Effector CD8 T Lymphoyctes in Three Consecutive Cases of Severe/Lethal H1N1/09 Influenza A Virus Infection (2010) (66)
Strong TCR Conservation and Altered T Cell Cross-Reactivity Characterize a B*57-Restricted Immune Response in HIV-1 Infection12 (2006) (63)
Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants (2005) (63)
Promises and challenges of adoptive T-cell therapies for solid tumours (2021) (62)
Maternal SDF1 3′A Polymorphism Is Associated with Increased Perinatal Human Immunodeficiency Virus Type 1 Transmission (2000) (62)
Antigen–specific release of β-chemokines by anti-HIV-1 cytotoxic T lymphocytes (1998) (61)
Dimorphic Motifs in D0 and D1+D2 Domains of Killer Cell Ig-Like Receptor 3DL1 Combine to Form Receptors with High, Moderate, and No Avidity for the Complex of a Peptide Derived from HIV and HLA-A*24021 (2009) (61)
Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine (2013) (60)
Direct relationship between virus load and systemic immune activation in HIV-2 infection. (2010) (59)
HLA-B may be more protective against HIV-1 than HLA-A because it resists negative regulatory factor (Nef) mediated down-regulation (2012) (59)
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease (2021) (58)
Multilayered Defense in HLA-B51–Associated HIV Viral Control (2011) (54)
Surfactant Protein A Binds to HIV and Inhibits Direct Infection of CD4+ Cells, but Enhances Dendritic Cell-Mediated Viral Transfer1 (2008) (53)
An HLA‐B35‐restricted epitope modified at an anchor residue results in an antagonist peptide (1996) (52)
Correlates of T-cell-mediated viral control and phenotype of CD8(+) T cells in HIV-2, a naturally contained human retroviral infection. (2013) (51)
Peptide-Major Histocompatibility Complex Dimensions Control Proximal Kinase-Phosphatase Balance during T Cell Activation (2009) (50)
A Pilot Feasibility Study in Establishing the Role of Ultrasound‐Guided Pleural Biopsies in Pleural Infection (The AUDIO Study) (2018) (50)
High Frequency of HIV Mutations Associated with HLA-C Suggests Enhanced HLA-C–Restricted CTL Selective Pressure Associated with an AIDS-Protective Polymorphism (2012) (49)
CCR5 promoter polymorphisms in a Kenyan perinatal human immunodeficiency virus type 1 cohort: association with increased 2-year maternal mortality. (2001) (48)
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV (2021) (47)
Interferon-induced transmembrane protein-3 rs12252-C is associated with rapid progression of acute HIV-1 infection in Chinese MSM cohort (2015) (46)
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells (2021) (45)
Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine (2005) (45)
Screening for HIV-specific T-cell responses using overlapping 15-mer peptide pools or optimized epitopes (2004) (45)
HV-1-specific cytotoxic T lymphocytes and breast milk HIV-1 transmission. (2009) (45)
Extensive HLA-driven viral diversity following a narrow-source HIV-1 outbreak in rural China. (2011) (43)
The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life (2012) (41)
Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. (1998) (39)
Identification of H5N1-specific T-cell responses in a high-risk cohort in vietnam indicates the existence of potential asymptomatic infections. (2012) (39)
The role of cytotoxic T-cells in HIV infection. (1998) (39)
Structure–function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans (2018) (38)
A Comprehensive Analysis of Key Immune Checkpoint Receptors on Tumor-Infiltrating T Cells From Multiple Types of Cancer (2019) (38)
Lack of Truncated IFITM3 Transcripts in Cells Homozygous for the rs12252-C Variant That is Associated With Severe Influenza Infection (2018) (38)
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza (2017) (38)
Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers (2021) (37)
Rescuing defective tumor-infiltrating T-cell proliferation in glioblastoma patients. (2016) (37)
Antibody evasion by the Brazilian P.1 strain of SARS-CoV-2 (2021) (36)
Highly avid, oligoclonal, early‐differentiated antigen‐specific CD8+ T cells in chronic HIV‐2 infection (2010) (35)
Enriched HLA-E and CD94/NKG2A Interaction Limits Antitumor CD8+ Tumor-Infiltrating T Lymphocyte Responses (2019) (35)
IFITM3: How genetics influence influenza infection demographically (2019) (34)
Immunisation with recombinant modified vaccinia virus Ankara expressing HIV‐1 gag in HIV‐1‐infected subjects stimulates broad functional CD4+ T cell responses (2006) (34)
Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response (2017) (32)
The T cell surface--how well do we know it? (2003) (32)
Acute Cytomegalovirus Infection Is Associated with Increased Frequencies of Activated and Apoptosis-Vulnerable T Cells in HIV-1-Infected Infants (2012) (32)
Gonococcal cervicitis is associated with reduced systemic CD8+ T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. (2002) (32)
SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study (2022) (31)
Correlates of Delayed Disease Progression in HIV-1-Infected Kenyan Children1 (2005) (31)
Characterization of an HLA‐C‐restricted CTL response in chronic HIV infection (2010) (31)
Antimycobacterial activity of fusaric acid from a mangrove endophyte and its metal complexes (2011) (30)
Tim-3 on peripheral CD4⁺ and CD8⁺ T cells is involved in the development of glioma. (2014) (30)
IFITM3 Rs12252-C Variant Increases Potential Risk for Severe Influenza Virus Infection in Chinese Population (2017) (29)
Surfactant Protein D Modulates HIV Infection of Both T-Cells and Dendritic Cells (2013) (29)
Antibody and T cell responses to Sinopharm/BBIBP-CorV in naive and previously infected individuals in Sri Lanka (2021) (29)
Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy (2018) (29)
Preservation of a critical epitope core region is associated with the high degree of flaviviral cross‐reactivity exhibited by a dengue‐specific CD4+ T cell clone (2008) (29)
Broad TCR Usage in Functional HIV-1-Specific CD8+ T Cell Expansions Driven by Vaccination during Highly Active Antiretroviral Therapy1 (2007) (28)
HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. (1998) (27)
Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells (2009) (26)
Effect of a Russian-backbone live-attenuated influenza vaccine with an updated pandemic H1N1 strain on shedding and immunogenicity among children in The Gambia: an open-label, observational, phase 4 study (2019) (26)
Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination (2015) (25)
Persistence of antibody and T cell responses to the Sinopharm/BBIBP-CorV vaccine in Sri Lankan individuals (2021) (25)
Self-Maintaining CD103+ Cancer-Specific T Cells Are Highly Energetic with Rapid Cytotoxic and Effector Responses (2019) (23)
Modified vaccinia Ankara expressing HIVA antigen stimulates HIV-1-specific CD8 T cells in ELISpot assays of HIV-1 exposed infants. (2005) (23)
The Antiviral Efficacy of HIV-Specific CD8+ T-Cells to a Conserved Epitope Is Heavily Dependent on the Infecting HIV-1 Isolate (2011) (22)
The Early Antibody-Dependent Cell-Mediated Cytotoxicity Response Is Associated With Lower Viral Set Point in Individuals With Primary HIV Infection (2018) (22)
Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells (2019) (21)
Four novel cytotoxic T-lymphocyte epitopes in the highly conserved major homology region of HIV-1 Gag, restricted through B*4402, B*1801, A*2601, B*70 (B*1509) (1998) (19)
HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades (2002) (19)
Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705. (1998) (19)
Downregulation of the T-Cell Receptor by Human Immunodeficiency Virus Type 2 Nef Does Not Protect against Disease Progression (2009) (18)
Prolonged Evolution of Virus-Specific Memory T Cell Immunity after Severe Avian Influenza A (H7N9) Virus Infection (2018) (18)
Divergent trajectories of antiviral memory after SARS-CoV-2 infection (2021) (18)
Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T-cells (2019) (18)
M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza. (2017) (18)
Transition From Long-Term Nonprogression to HIV-1 Disease Associated With Escape From Cellular Immune Control (2008) (17)
Broadly Inhibiting Antineuraminidase Monoclonal Antibodies Induced by Trivalent Influenza Vaccine and H7N9 Infection in Humans (2019) (17)
Phenotypic Characterization of HIV-Specific CD8+ T Cells during Early and Chronic Infant HIV-1 Infection (2011) (17)
Interleukin-10 responses to therapeutic vaccination during highly active antiretroviral therapy and after analytical therapy interruption (2009) (16)
Malignancy and IFITM3: Friend or Foe? (2020) (16)
IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models (2020) (16)
Therapeutic efficacy of brucea javanica oil emulsion (BJOE) combined with transcatheter hepatic arterial chemoembolization (TACE) in patients with primary liver cancer. (2015) (16)
Lysyl oxidase genetic variants and the prognosis of glioma (2014) (14)
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV (2021) (14)
P17-28 LB. The antiviral efficacy of HIV-specific CD8+ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate (2009) (13)
The bacteriology of pleural infection (TORPIDS): an exploratory metagenomics analysis through next generation sequencing (2022) (13)
Dominant CD4‐dependent RNA‐dependent RNA polymerase‐specific T‐cell responses in children acutely infected with human enterovirus 71 and healthy adult controls (2014) (12)
Association analysis between HLA-A, -B, -C, -DRB1, and -DQB1 with nasopharyngeal carcinoma among a Han population in Northwestern China. (2014) (12)
Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant from Naturally Acquired and Vaccine Induced Antibody Immunity (2021) (12)
The effect of cytokine profiles on the viral response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection. (2011) (12)
Dying T cells trigger autoimmunity in HIV (2007) (11)
Prostitutes in Nairobi Responses in the Cervix of HIV-1-Resistant Lymphocyte + HIV-1-Specific Mucosal CD 8 (2000) (11)
Comparison of surgical procedures implemented in recent years for patients with grade III and IV hemorrhoids: a network meta-analysis (2019) (11)
Immunodominance complexity: lessons yet to be learned from dominant T cell responses to SARS-COV-2 (2021) (11)
Erratum: HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women (Nature Medicine 1, 59-64, (1995)) (1995) (11)
An immunodominant NP105–113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease (2021) (11)
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac) (2021) (10)
Correction: Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine (2011) (10)
Antibody and T-cell responses to a single dose of the AZD1222/Covishield vaccine in previously SARS-CoV-2 infected and naive health care workers in Sri Lanka (2021) (10)
Human cancer germline antigen-specific cytotoxic T cell—what can we learn from patient (2020) (10)
Revisiting the Effect of Acute P. falciparum Malaria on Epstein-Barr Virus: Host Balance in the Setting of Reduced Malaria Endemicity (2012) (9)
The presence of prolines in the flanking region of an immunodominant HIV‐2 gag epitope influences the quality and quantity of the epitope generated (2015) (9)
Monitoring of Peptide-Specific and Gamma Interferon-Productive T Cells in Patients with Active and Convalescent Tuberculosis Using an Enzyme-Linked Immunosorbent Spot Assay (2012) (9)
Multilayered HIV-1 gag-specific T-cell responses contribute to slow progression in HLA-A∗30-B∗13-C∗06-positive patients (2015) (9)
Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome (2018) (9)
HIV: Tired T cells turn around (2006) (9)
High Level Antibody Response to Pandemic Influenza H1N1/09 Virus Is Associated With Interferon-Induced Transmembrane Protein-3 rs12252-CC in Young Adults (2018) (8)
T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles (2022) (8)
Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD 40 ligand from helper T cells (2019) (8)
Combinatorial HLA-peptide bead libraries for high throughput identification of CD8⁺ T cell specificity. (2014) (8)
High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China (2019) (8)
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients (2019) (8)
nef gene sequence variation among HIV‐1‐infected African children * (2006) (8)
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments (2020) (7)
HIV-1–Specific Cytotoxic T Lymphocytes and Breast Milk HIV-1 Transmission (2010) (7)
Multiple T-cell responses are associated with better control of acute HIV-1 infection (2016) (7)
Proliferation, But Not Interleukin 2 Production, of Gag-Specific CD8+ T Cells Is Associated With Low HIV Viremia and High CD4 Counts in HIV-1-Infected Chinese Individuals (2009) (7)
Identification of KIR3DL1*0050103 by the sequence-based techniques. (2013) (6)
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV (2021) (6)
Genomic analysis of HIV type 1 strains derived from a mother and child pair of long-term nonprogressors. (2007) (6)
Identification of KIR3DL1*0150208 using long-range sequence-based techniques. (2014) (6)
Single-Molecule, Super-Resolution, and Functional Analysis of G Protein-Coupled Receptor Behavior Within the T Cell Immunological Synapse (2021) (6)
Killer-cell immunoglobulin-like receptors associate with HIV-1 infection in a narrow-source Han Chinese cohort (2018) (6)
Defective Interferon Gamma Production by Tumor-Specific CD8+ T Cells Is Associated With 5′Methylcytosine-Guanine Hypermethylation of Interferon Gamma Promoter (2020) (6)
Association among helicobacter pylori infection, gastrin level and colorectal cancer in patients aged 50 years and over (2020) (5)
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation (2021) (5)
Erratum: Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals (Journal of Clinical Investigation (2008) 118, 10, (3478-3490) doi:10.1172/JCI32460) (2012) (5)
Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma (2018) (5)
Kinetics of immune responses to the AZD1222/Covishield vaccine with varying dose intervals in Sri Lankan individuals (2021) (5)
HLA-associated polymorphisms in the HIV-2 capsid highlight key differences between HIV-1 and HIV-2 immune adaptation (2018) (5)
Defining ELISpot cut-offs from unreplicated test and control wells (2013) (5)
PD-1 Expression Status on CD8+ Tumour Infiltrating Lymphocytes Associates With Survival in Cervical Cancer (2021) (5)
HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate. (2002) (5)
Clinical perspective and practices on pleural effusions in chronic systemic inflammatory diseases (2020) (5)
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages (2021) (5)
Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling (2008) (4)
Report of a novel KIR3DS1*0130104 allele discovered using advanced molecular techniques. (2014) (4)
A 2 Amino Acid Shift in Position Leads to a Substantial Difference in the Pattern of Processing of 2 HIV-1 Epitopes (2012) (4)
Pathogenesis of influenza: virus–host interactions (2011) (4)
Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects (2016) (4)
Interferon-induced transmembrane protein-3 rs12252-CC is associated with low differentiation and progression of hepatocellular carcinoma (2019) (4)
Elevated CD54 expression renders CD4+ T cells susceptible to NK cell-mediated killing. (2019) (4)
IFITM3‐specific antibody reveals IFN preferences and slow IFN induction of the antiviral factor IFITM3 in humans (2020) (4)
Dengue virus co-opts innate type 2 pathways to escape early control of viral replication (2022) (4)
HIV vaccines: The myth of cross-reactive T cells (2003) (4)
The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study. (2022) (4)
Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19 (2022) (3)
Detection of broad functional gag-specific CD4+ T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen (2006) (3)
Immune responses to Sinopharm/BBIBP‐CorV in individuals in Sri Lanka (2022) (3)
S24 A phase i feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (the audio study) (2017) (3)
[Epidemiologic study and HLA analysis of highly exposed to HIV but persistently seronegative subjects (HEPS) in commercial blood donors in China]. (2006) (3)
Effect of acupuncture method of removing-stasisand resuscitating on the consciousness of patients with severe traumatic brain injury (2020) (3)
CD8+ cytotoxic T lymphocytes in human influenza virus infection. (2015) (3)
Structure–function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans (2018) (3)
Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak (2018) (3)
A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort (2016) (3)
Association between circulating CD39+CD8+ T cells pre-chemoradiotherapy and prognosis in patients with nasopharyngeal carcinoma (2021) (3)
Low basal expression and slow induction of IFITM3 puts immune cells at risk of influenza A infection (2019) (3)
Apoptotic bone marrow CD34+ cells in cirrhotic patients. (2011) (2)
Malignant pleural effusion: Updates in diagnosis, management and current challenges (2022) (2)
Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral control (2022) (2)
T Cell Therapy Targeted on HLA-A02 Restricted HIV Antigen Epitopes: An Open Label Cellular Therapy Trial Using CD8+ T Cell (2019) (2)
SARS-CoV-2 mutations affect proteasome processing to alter CD8+ T cell responses (2022) (2)
Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo (2014) (2)
Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection (2022) (2)
Associations of Human Leukocyte Antigen-DRB1 Alleles with Nasopharyngeal Carcinoma and Its Clinical Significance in Xinjiang Uyghur Autonomous Region of China (2016) (2)
Reply to "Failure to detect production of IL-10 by activated human neutrophils" (2011) (2)
Killer-cell immunoglobulin-like receptor gene 3DL1*077 isolated using long-range sequence-based techniques. (2014) (2)
The impact of an updated pandemic H1N1 strain on shedding and immunogenicity to Russian-backbone live attenuated influenza vaccine among children in The Gambia: an open-label, observational, phase 4 study (2019) (2)
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial (2021) (2)
HLA allele distributions and associations in a cohort of LTNPs from China (2011) (2)
Primary CMV infection: a co-factor HIV-1 disease progression in African infants? (2008) (2)
HLA-A*30:01 and HLA-A*33:03 are the protective alleles while HLA-A*01:01 serves as the susceptible gene for cervical cancer patients in Xinjiang, China (2018) (2)
Conflicting selective forces affect CD8 T-cell receptor contact sites in an HLA-A2 immunodominant HIV epitope. (2006) (1)
Hepatitis C virus nonstructural protein specific T cells are associated with virological responses to combination therapy in chronic HCV patients (2012) (1)
Antigen-sensitive CD8 T-cell clones with tough HIV-1 suppression (2013) (1)
HIV-2 gene product-specific T cell responses and viraemia control (2006) (1)
HIV-1–Specific Immunodominant T-Cell Responses Drive the Dynamics of HIV-1 Recombination Following Superinfection (2022) (1)
InfectionDistinguishes HIV-2 from HIV-1 Maintenance of HIV-Specific CD4+ T Cell (2013) (1)
A statistical approach to determining responses to individual peptides from pooled-peptide ELISpot data. (2016) (1)
Detection of a novel killer-cell immunoglobulin-like receptor allele - KIR3DL1*0150207 - in Asian individuals. (2014) (1)
Distribution of HLA-A alleles and its relation to clinical outcome in Uyghur and Han patients with advanced squamous cell cervical cancer in Xinjiang, China (2018) (1)
Identification of the KIR3DL1*0050105 allele by sequence-based techniques. (2014) (1)
Short communication: broader T cell responses directed against human immunodeficiency virus type 1 in infected Chinese individuals through blood-borne transmission in comparison with mucosal transmission. (2013) (1)
Two novel KIR3DL1 alleles, 3DL1*0150205 and 3DL1*0150206, identified by full-length DNA sequencing. (2014) (1)
Variations in dynamic tumor-associated antigen-specific T cell responses correlate with HCC recurrence after thermal ablation (2022) (1)
Human cancer germline antigen-specific cytotoxic T cell—what can we learn from patient (2020) (1)
HLA correlates in a cohort of slow progressors from China: effects on HIV-1 disease progression (2013) (1)
[Clinical observation of target-controlled remifentanil infusion combined with propofol and doxapram in painless artificial abortion]. (2006) (1)
IFITM3 regulates virus-induced inflammatory cytokine production by titrating Nogo-B orchestration of TLR responses (2021) (1)
HLA-A*02-B*46 haplotype: an adverse prognostic factor in Han patients with nasopharyngeal carcinoma (2016) (1)
Author response: Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells (2019) (1)
Report of a novel activating killer-cell immunoglobulin-like receptor allele 3DS1*078 identified using sequence-based typing. (2014) (1)
Identification of KIR3DL1*0200101 by long-range sequence-based techniques. (2014) (1)
Analysis of HIV-1 envelope evolution suggests antibody-mediated selection of common epitopes among Chinese former plasma donors from a narrow-source outbreak (2018) (0)
I-24 HIV-specific T-cell responses in a cohort of slow progressors in China (2008) (0)
InfectionDistinguishes HIV-2 from HIV-1 T Cell + Maintenance of HIV-Specific CD4 (2017) (0)
Transfer Enhances Dendritic Cell-Mediated Viral Cells , but + Inhibits Direct Infection of CD 4 Surfactant Protein A Binds to HIV and Mitchell (2008) (0)
A novel full length KIR3DL1*0070103 identified by molecular typing. (2013) (0)
Description of a novel KIR3DL1*0050104 allele identified using sequence-based techniques. (2014) (0)
Spectrum and kinetic of T cell responses to dengue virus epitopes and the influence of hla polymorphisms in dengue disease pathogenesis (2006) (0)
P20-19 LB. Extensive HLA-driven viral diversity following a single-source HIV-1 outbreak in rural China (2009) (0)
KIR3DS1*0130108 isolated using full length sequence-based typing. (2014) (0)
Phenotypic characterization of HIV-specific CD8 T cells during acute infant HIV infection (2009) (0)
Functional analysis of candidate CD8+T cell-derived anti-HIV factors (2005) (0)
Clonotypic architecture of a Gag‐specific CD8+ T‐cell response in chronic human HIV‐2 infection (2020) (0)
Correction. The presence of prolines in the flanking region of an immunodominant HIV-2 gag epitope influences the quality and quantity of the epitope generated. (2015) (0)
Characterisation of immune responses within HLA-B*40+patients in a Chinese HIV-1 infected slow progressor cohort (2010) (0)
Killer-cell immunoglobulin-like receptor (KIR) genetic diversity in a unique HIV-1 cohort in China (2014) (0)
Construction and application of cell fines screening Mycobacterium tuberculosis-specific tetramers of CD4+α/β T cell receptor (2009) (0)
Cytotoxic T-Cells in HIV-1: "The Good" and "The Bad" (2012) (0)
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design (2022) (0)
The HLA-A*02-B*46 Haplotype is an Adverse Prognostic Factor in Han Nasopharyngeal Carcinoma Patients (2015) (0)
TCR-Identical CD8+T-Cells Can Have Distinct Killing Efficacy Determined By Events Beyond the T-Cell Receptor (2017) (0)
High polymorphism rates in well-known T cell epitopes restricted by protective HLA alleles during HIV infection are associated with rapid disease progression in early-infected MSM in China (2019) (0)
VIROLOGICAL RESPONSES TO COMBINATION THERAPY IN PATIENTS CHRONICALLY INFECTED WITH HCV GENOTYPE 1B ARE RELATED WITH DYNAMIC OF HCV-NS-SPECIFIC T CELL RESPONSES (2010) (0)
Activated innate lymphoid cell populations accumulate in human tumour tissues (2018) (0)
Evolutionary Dynamics of HIV-2 Infection in a Community Cohort of West Africa (2009) (0)
P140 MODELLING THE LIVER IMMUNE MICROENVIRONMENT: FACTORS THAT DEFINE ANTIVIRAL ACTIVITY OF T CELLS (2014) (0)
Distinct antibody-mediated selection in a narrow-source HIV-1 outbreak among Chinese former plasma donors (2017) (0)
Human Leukocyte Antigen-A Allele Distribution in Nasopharyngeal Carcinoma Patients Showing Anti-Melanoma-Associated Antigen A or Synovial Sarcoma X-2 T Cell Response in Blood (2018) (0)
HIV-1-Infected Kenyan Children Correlates of Delayed Disease Progression in (2005) (0)
Multi-layered Gag-specific immunodominant responses contribute to improved viral control in the CRF01_AE subtype of HIV-1-infected MSM subjects (2016) (0)
Molecular Basis for the Recognition of HIV Nef138-8 Epitope by a Pair of Human Public T Cell Receptors (2022) (0)
Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy (2018) (0)
B*57-Restricted Immune Response in HIV-1 Cross-Reactivity Characterize a Strong TCR Conservation and Altered T Cell (2017) (0)
Immunodominant CD8+ T cell responses to HIV-1 infection - 'The good and the bad' (2011) (0)
Archives of Gynecology and Obstetrics Frequency distribution of HLA alleles and haplotypes in Uyghur women with advanced squamous cell cervical cancer and relation to HPV status and clinical outcome (2018) (0)
Can Surfactant Protein D Inhibit HIV Infection in the Lung (2013) (0)
Children with Dengue to Commencement of Capillary Leakage in T Cell Responses in Relation + Timing of CD8 (2010) (0)
The effect of anti--CD4--epirubicin to T lymphoma in vitro and in vivo (2006) (0)
P08-05. Does increased expression of HLA-C allow better control of HIV-1 viral load? (2009) (0)
HIV-1-Infected Infants Responses during the First Year of Life in ( HIV-1 )-Specific Gamma Interferon Immunodeficiency Virus Type 1 Longitudinal Assessment of Human (2005) (0)
Distinct tumour antigen-specific T-cell immune response profiles at different hepatocellular carcinoma stages (2021) (0)
Influence of HIV-1 specific T cell response on the progression of HIV-1 infection (2009) (0)
MiR-128-3p increases sensitivity of hepatoma cells to oxaliplatin by targeting Lin28B (2018) (0)
Omicron BA.1 breakthrough infections in inactivated COVID-19 vaccine recipients induced distinct pattern of antibody and T cell responses to different Omicron sublineages (2023) (0)
CTL responses to HIV-1 during acute and chronic infection (2008) (0)
in HIV-1-Infected Infants Activated and Apoptosis-Vulnerable T Cells Associated with Increased Frequencies of Acute Cytomegalovirus Infection Is (2012) (0)
Biopanning of specific peptide for SARS-CoV-2 nucleocapsid protein and enzyme-linked immunosorbent assay-based antigen assay (2023) (0)
ST111 Immune selection and vpu variability in a unique narrow source HIV-Positive village cohort (2013) (0)
Human papilloma virus E1-specific T cell immune response is associated with the prognosis of cervical cancer patients with squamous cell carcinoma (2018) (0)
High pro-inflammatory cytokine secretion and selective depletion of high avidity cross-reactive cytotoxic T-cells in the pathogenesis of acute secondary dengue virus infection (2007) (0)
1663. Marked Improvement in Pandemic H1N1 Component Shedding and Immunogenicity in 2017–2018 Russian-Backbone Live Attenuated Influenza Vaccine (LAIV) in Gambian Children (2018) (0)
Synthetic antigen-presenting cells reveal the diversity and functional specialisation of extracellular vesicles composing the fourth signal of T cell immunological synapses (2021) (0)
Antiretroviral Therapy Driven by Vaccination during Highly Active T Cell Expansions + HIV-1-Specific CD8 Broad TCR Usage in Functional (2007) (0)
Late Breaking Abstract - A phase I feasibility study in establishing the role of ultrasound-guided pleural biopsies in pleural infection (The AUDIO study) (2017) (0)
Simple peritoneal lavage combined with venous-venous hemofiltration for severe acute pancreatitis (2011) (0)
S46 Identification of pleural infection bacterial patterns. The oxford pleural infection metagenomics study (2021) (0)
Patient derived pleural mesothelioma cell lines, can be used as tools, to guide patient stratification (2019) (0)
Generation of immune checkpoint knock-out human antigen-specific T cells via CRISPR/Cas9-mediated genetic engineering (2016) (0)
The bacteriology of pleural infection using next generation sequencing: The Oxford Pleural Infection Metagenomics Studies (TORPIDS) (2022) (0)
Anti-CD8 antibody induced transcriptional remodelling in HIV-specific CD8 T cells secreting Anti-HIV-1 factors (2004) (0)
Clinical study on effects of removing-stasis and resuscitating methods on conscious state of patients with severe cerebral injury (2010) (0)
Studying the biological properties of pleural fluid: pleural fluid alone is adequate for cancer cell proliferation in vitro (2020) (0)
Effect of Modified Xuefu Zhuyu Decoction on Post-stroke Depression:A Randomized Controlled Trial (2010) (0)
A longitudinal analysis of immune escapes from HLA-B*13-restricted T-cell responses at early stage of CRF01_AE subtype HIV-1 infection and implications for vaccine design (2022) (0)
Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study (2018) (0)
The role of CD8+ T-cell responses in the pathogenesis of HIV-2, a naturally contained human retroviral infection (2013) (0)
Study of the plasma thrombomodulin and von Willebrand factor determination in the diagnosis and treatment of acute ischemic colitis (2012) (0)
Patient derived malignant pleural effusion cell cultures as a platform to understand pleural malignancies and advance personalised treatment (2022) (0)
Effect of Glycyrrhizin combined with puerarin on serum leptin and insulin resistance in patients with non-alcoholic fatty liver disease (2014) (0)
Detection of a novel KIR3DL1*0150210 allele by sequencing. (2015) (0)
Analysis of H5N1 specific T cell responses in a high risk cohort in VietNam indicates possible asymptomatic infection (2010) (0)
The identification of a killer cell immunoglobulin-like receptor 3DL1*0150209 in an Asian population using molecular techniques. (2015) (0)
A novel KIR3DL1*0070104 allele found in individuals from Asia. (2014) (0)
Omicron BA.1/BA.2 infections in triple-vaccinated individuals enhance a diverse repertoire of mucosal and blood immune responses (2023) (0)
A novel KIR3DS1*0130107 allele isolated by sequencing from an Asian donor (2014) (0)
S130 Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine (2018) (0)
KIR3DS1*0130109: a novel activating three-domain KIR identified using sequence-based typing. (2015) (0)
Full length KIR3DS1*0130110 allele isolated by SBT. (2014) (0)
Lack of truncated IFITM3 transcripts in cells homozygous for the rs12252-C variant infection (2017) (0)
Full-length genomic sequence of a new KIR3DL1*0150203 allele. (2014) (0)
Association of pretreatment serum macrophage inflammatory protein (MIP)-1b levels with sustained virological response to re-treatment in antiviral-experienced patients with chronic hepatitis C virus infection (2012) (0)
The KIR3DS1*0130105 allele identified using high-resolution sequence-based typing. (2014) (0)
KIR3DS1*0130111: a novel KIR allele identified using molecular typing methods. (2015) (0)
A novel full-length KIR3DS1*0130106 allele identified by sequencing. (2014) (0)
Long-range sequencing revealed a new KIR3DL1*0150204 allele in 20 individuals of Asian descent. (2014) (0)

This paper list is powered by the following services:

Other Resources About Tao Dong

en.wikipedia.org

What Schools Are Affiliated With Tao Dong?

Tao Dong is affiliated with the following schools: